Indivior Pharmaceuticals, Inc. (DELISTED) (INDV:DL)
36.28
+0.91
(+2.57%)
USD |
NASDAQ |
Nov 02, 16:00
Indivior Pharmaceuticals Max Drawdown (5Y) : 96.00% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 96.00% |
| September 30, 2026 | 96.00% |
| August 31, 2026 | 96.00% |
| July 31, 2026 | 96.00% |
| June 30, 2026 | 96.00% |
| May 31, 2026 | 96.00% |
| April 30, 2026 | 96.00% |
| March 31, 2026 | 96.00% |
| February 28, 2026 | 96.00% |
| January 31, 2026 | 96.00% |
| December 31, 2025 | 96.00% |
| November 30, 2025 | 96.00% |
| October 31, 2025 | 96.00% |
| September 30, 2025 | 96.00% |
| August 31, 2025 | 96.00% |
| July 31, 2025 | 96.00% |
| June 30, 2025 | 96.00% |
| May 31, 2025 | 96.00% |
| April 30, 2025 | 96.00% |
| March 31, 2025 | 96.00% |
| February 28, 2025 | 96.00% |
| January 31, 2025 | 96.00% |
| December 31, 2024 | 96.00% |
| November 30, 2024 | 96.00% |
| October 31, 2024 | 96.00% |
| Date | Value |
|---|---|
| September 30, 2024 | 96.00% |
| August 31, 2024 | 96.00% |
| July 31, 2024 | 96.00% |
| June 30, 2024 | 96.00% |
| May 31, 2024 | 96.00% |
| April 30, 2024 | 96.00% |
| March 31, 2024 | 96.00% |
| February 29, 2024 | 96.00% |
| January 31, 2024 | 96.00% |
| December 31, 2023 | 96.00% |
| November 30, 2023 | 100.00% |
| October 31, 2023 | 100.00% |
| September 30, 2023 | 100.00% |
| August 31, 2023 | 100.00% |
| July 31, 2023 | 100.00% |
| June 30, 2023 | 100.00% |
| May 31, 2023 | 100.00% |
| April 30, 2023 | 100.00% |
| March 31, 2023 | 100.00% |
| February 28, 2023 | 100.00% |
| January 31, 2023 | 100.00% |
| December 31, 2022 | 100.00% |
| November 30, 2022 | 100.00% |
| October 31, 2022 | 100.00% |
| September 30, 2022 | 100.00% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Supernus Pharmaceuticals, Inc. | 57.68% |
| Bristol Myers Squibb Co. | 47.67% |
| Eli Lilly & Co. | 34.47% |
| Ligand Pharmaceuticals, Inc. | 72.85% |
| Amneal Pharmaceuticals, Inc. | 94.77% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 2.645 |
| Beta (5Y) | 1.139 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 163.7% |
| Historical Sharpe Ratio (5Y) | 0.0733 |
| Historical Sortino (5Y) | 0.3238 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 21.49% |